Azzur opens new on-demand cleanroom facility in California The company’s Azzur Cleanrooms on Demand division has established another facility in Vista, a city in the San Diego Area, for life-sciences operations.
Azzur Cleanrooms on Demand (a division of Azzur Group) has opened the doors on its latest facility in Vista, California. The facility is the second location, joining the first location that opened in 2018 in Waltham, Massachusetts.
In addition to cleanroom facilities. The Cleanrooms on Demand model offers early-stage life-sciences clients materials management, storage, asset management, and supply chain solutions. The facilities are intended to enable clients to focus on research and early-stage Current Good Manufacturing Practice (cGMP) manufacturing, without the heavy investment associated with ownership and maintenance of such infrastructure. cGMP manufacturing without the burden of facility ownership and maintenance.
A panel of experts at the online pharma event discussed how the pandemic created opportunities for the field but could also lead to significant challenges.
Artificial intelligence can elevate pharma manufacturing According to a leader from industrial AI specialist AspenTech, AI can help avoid costly maintenance interruptions by predicting when upkeep is needed.
Any unnecessary downtime can be expensive for pharmaceutical manufacturing operations. What’s more, unplanned stoppages can delay the delivery of much-needed product, potentially causing damage to a company’s reputation.
David Leitham, senior vice president and general manager at industrial artificial intelligence (AI) technology firm AspenTech, recently spoke with Outsourcing-Pharma (OSP) about how AI can be put to use to help predict when maintenance is needed, and avoid unplanned or over-maintenance.
OSP: Could you please share an ‘elevator presentation’ description of AspenTech?
An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes.
The two companies plan to collaboratively explore ways to combine 3D printing and nanotechnology, in order to create nanoparticle-enabled dosage forms.